Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$34.63
0.150.44%
At close: -
$34.40
-0.23-0.66%
After Hours: 4:26 PM EDT
Comments
Loading...
American Healthcare REIT Analyst Ratings and Price Targets | NYSE:AHR | Benzinga
American Healthcare REIT Inc has a consensus price target of $29.64 based on the ratings of 11 analysts. The high is $45 issued by Morgan Stanley on May 20, 2025. The low is $14 issued by Citigroup on March 4, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Jefferies, and Keybanc on May 20, 2025, April 28, 2025, and March 31, 2025, respectively. With an average price target of $38.67 between Morgan Stanley, Jefferies, and Keybanc, there's an implied 12.40% upside for American Healthcare REIT Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Jefferies
Keybanc
RBC Capital
Citizens Capital Markets
1calculated from analyst ratings
Analyst Ratings for American Healthcare REIT
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/20/2025 | Buy Now | 30.81% | Morgan Stanley | Ronald Kamdem62% | $37 → $45 | Maintains | Overweight | Get Alert |
| 04/28/2025 | Buy Now | 7.56% | Jefferies | Joe Dickstein71% | → $37 | Initiates | → Buy | Get Alert |
| 03/31/2025 | Buy Now | -1.16% | Keybanc | Austin Wurschmidt56% | $35 → $34 | Maintains | Overweight | Get Alert |
| 03/25/2025 | Buy Now | 7.56% | Morgan Stanley | Ronald Kamdem62% | $36 → $37 | Maintains | Overweight | Get Alert |
| 03/19/2025 | Buy Now | -1.16% | RBC Capital | Michael Carroll62% | $34 → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 03/04/2025 | Buy Now | 1.74% | Citizens Capital Markets | Aaron Hecht55% | $30 → $35 | Maintains | Market Outperform | Get Alert |
| 12/30/2024 | Buy Now | -15.7% | Morgan Stanley | Ronald Kamdem62% | $27 → $29 | Maintains | Overweight | Get Alert |
| 11/18/2024 | Buy Now | -12.79% | RBC Capital | Michael Carroll62% | $28 → $30 | Maintains | Outperform | Get Alert |
| 11/15/2024 | Buy Now | -15.7% | Truist Securities | Michael Lewis68% | $27 → $29 | Maintains | Buy | Get Alert |
| 09/24/2024 | Buy Now | -9.88% | B of A Securities | Joshua Dennerlein49% | $27 → $31 | Maintains | Buy | Get Alert |
| 09/20/2024 | Buy Now | -21.51% | Truist Securities | Michael Lewis68% | $22 → $27 | Maintains | Buy | Get Alert |
| 09/20/2024 | Buy Now | -12.79% | JMP Securities | Aaron Hecht55% | $18 → $30 | Maintains | Market Outperform | Get Alert |
| 09/20/2024 | Buy Now | -18.6% | Keybanc | Austin Wurschmidt56% | $27 → $28 | Maintains | Overweight | Get Alert |
| 09/16/2024 | Buy Now | -21.51% | Keybanc | Austin Wurschmidt56% | $16 → $27 | Maintains | Overweight | Get Alert |
| 09/03/2024 | Buy Now | -36.05% | Truist Securities | Michael Lewis68% | $17 → $22 | Maintains | Buy | Get Alert |
| 08/22/2024 | Buy Now | -36.05% | Morgan Stanley | Ronald Kamdem62% | $17 → $22 | Maintains | Overweight | Get Alert |
| 08/20/2024 | Buy Now | -21.51% | B of A Securities | Joshua Dennerlein49% | $19 → $27 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | -44.77% | B of A Securities | — | $16 → $19 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | -47.67% | JMP Securities | Aaron Hecht55% | $16 → $18 | Maintains | Market Outperform | Get Alert |
| 07/01/2024 | Buy Now | -50.58% | Truist Securities | Michael Lewis68% | $16 → $17 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | -53.49% | JMP Securities | Aaron Hecht55% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/03/2024 | Buy Now | -53.49% | Truist Securities | Michael Lewis68% | $17 → $16 | Maintains | Buy | Get Alert |
| 03/25/2024 | Buy Now | -53.49% | JMP Securities | Aaron Hecht55% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/25/2024 | Buy Now | -50.58% | Truist Securities | Michael Lewis68% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2024 | Buy Now | -47.67% | Barclays | Anthony Powell51% | → $18 | Initiates | → Overweight | Get Alert |
| 03/04/2024 | Buy Now | -56.4% | RBC Capital | Michael Carroll62% | → $15 | Initiates | → Outperform | Get Alert |
| 03/04/2024 | Buy Now | -53.49% | JMP Securities | Aaron Hecht55% | → $16 | Initiates | → Market Outperform | Get Alert |
| 03/04/2024 | Buy Now | -50.58% | Truist Securities | Michael Lewis68% | → $17 | Initiates | → Buy | Get Alert |
| 03/04/2024 | Buy Now | -50.58% | Morgan Stanley | Ronald Kamdem62% | → $17 | Initiates | → Overweight | Get Alert |
| 03/04/2024 | Buy Now | -59.3% | Citigroup | Michael Griffin67% | → $14 | Initiates | → Neutral | Get Alert |
| 03/04/2024 | Buy Now | -53.49% | Keybanc | Austin Wurschmidt56% | → $16 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for American Healthcare REIT (AHR) stock?
The latest price target for American Healthcare REIT (NYSE:AHR) was reported by Morgan Stanley on May 20, 2025. The analyst firm set a price target for $45.00 expecting AHR to rise to within 12 months (a possible 30.81% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for American Healthcare REIT (AHR)?
The latest analyst rating for American Healthcare REIT (NYSE:AHR) was provided by Morgan Stanley, and American Healthcare REIT maintained their overweight rating.
When was the last upgrade for American Healthcare REIT (AHR)?
There is no last upgrade for American Healthcare REIT
When was the last downgrade for American Healthcare REIT (AHR)?
There is no last downgrade for American Healthcare REIT.
When is the next analyst rating going to be posted or updated for American Healthcare REIT (AHR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of American Healthcare REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for American Healthcare REIT was filed on May 20, 2025 so you should expect the next rating to be made available sometime around May 20, 2026.
Is the Analyst Rating American Healthcare REIT (AHR) correct?
While ratings are subjective and will change, the latest American Healthcare REIT (AHR) rating was a maintained with a price target of $37.00 to $45.00. The current price American Healthcare REIT (AHR) is trading at is $34.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
